Clinical Trials · NCT06975111

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

RecruitingPhase 2/Phase 3Semaglutide (Investigational)
Phase
Phase 2/Phase 3
Recruitment status
Recruiting
Sponsor
University of Colorado, Denver
Enrollment
200
Start date
Mar 2026
Locations
3 sites, United States
Primary endpoint
Epigenetic aging measurements of "PhenoAge"
View Semaglutide compound reference